"Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model." Circulation
Selecting I agree confirms the above and your acceptance of our Research Disclaimer and Terms of Sale
Adverse Events and Treatment Discontinuation With GLP-1s, side effects are a common and expected consideration and can influence whether patients remain on treatment
Karyocytomegaly and/or Multinucleated Hepatocytes (Figures 65 and 66) Synonyms Karyocytomegaly, multinucleated hepatocytes, binucleated hepatocytes, karyomegaly, nuclear hypertrophy, hepatocytomegaly, polyploidy, anisonucleosis, anisokaryosis
In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after drugmakers for marketing glucagon-like peptide-1 (GLP-1) receptor agonists and similar medications without regulatory approval